Vista Eyecare, Inc. v. Neumann (In Re Vista Eyecare, Inc.)

283 B.R. 613, 2002 Bankr. LEXIS 1066, 40 Bankr. Ct. Dec. (CRR) 57, 2002 WL 31174521
CourtUnited States Bankruptcy Court, N.D. Georgia
DecidedAugust 13, 2002
Docket16-70558
StatusPublished
Cited by2 cases

This text of 283 B.R. 613 (Vista Eyecare, Inc. v. Neumann (In Re Vista Eyecare, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vista Eyecare, Inc. v. Neumann (In Re Vista Eyecare, Inc.), 283 B.R. 613, 2002 Bankr. LEXIS 1066, 40 Bankr. Ct. Dec. (CRR) 57, 2002 WL 31174521 (Ga. 2002).

Opinion

FINDINGS OF FACT AND CONCLUSIONS OF LAW ON OBJECTION OF DEBTORS TO PROOF OF CLAIM OF MYREL NEUMANN

JAMES E. MASSEY, Bankruptcy Judge.

Vista Eyecare, Inc., formerly known as National Vision Associates, Ltd., (“Vista”) and related Debtors object to proof of claim no. 947, which asserts a general unsecured claim in the amount of $900,000, on the grounds that the claim is unenforceable under O.C.GA. § 14-2-640 or must be subordinated to the claims of general unsecured creditors pursuant to 11 U.S.C. § 510(b). RCG Carpathia Master Fund, Ltd., as assignee of Myrel Neumann, filed the proof of claim on November 29, 2000 and subsequently reassigned it to Neu-mann. The Court held an evidentiary hearing on the objection on April 25, 2002. Pursuant to Rule 52 of the Federal Rules of Civil Procedure made applicable by Rule 7052 of the Federal Rules of Bankruptcy Procedure, the Court makes these findings of fact and conclusions of law. The Court has included in its findings of fact, the facts to which the parties stipulated in the Consolidated Pretrial Order dated April 24, 2002.

Vista sells eyeglasses and contact lenses and provides optical and optometric goods and services. It calls its shops “vision centers,” which it operates as stand-alone stores in shopping centers and malls and as host departments in Wal-Mart stores. In 1997, Vista began a plan to diversify its revenue base by acquiring chains in the free-standing optical market. Vista is, and was from 1997 through the petition date, a reporting company under the Securities and Exchange Act of 1934.

In the fall of 1997, Vista purchased all of the outstanding stock of Midwest Vision, Inc. from Myrel Neumann, whose entrepreneurship grew out of his profession as a doctor of optometry. Midwest operated 51 retail optical stores and one optical lab. Dr. Neumann was represented by legal counsel in connection with the transaction.

Dr. Neumann did not initiate the transaction. A broker working with Vista had contacted him and arranged a meeting with Vista’s president. Thereafter the parties began to negotiate a deal. In making a proposal to acquire Dr. Neumann’s stock in Midwest, the components of consideration offered by Vista included cash, a note, Vista common stock, a covenant not to compete and an employment contract.

Dr. Neumann initially resisted accepting stock in Vista as part of the purchase price *616 and wanted more cash instead. Vista resisted his demands, and he changed his mind. Under the Stock Purchase Agreement, dated September 15, 1997, the final consideration (which had been subject to accounting adjustments) paid to Dr. Neu-mann for the capital stock of Midwest included $1,860,000 in cash, a promissory note for $620,000, an employment agreement, including a payment for a covenant not to compete, valued at $658,000, one hundred thousand unregistered shares of common stock of Vista and a put option with respect to those shares, the terms of which were set forth in a Put Option Agreement dated October 1, 1997. The parties stipulated that this consideration had “an aggregate stated face value of between $3,838,000 and $4,038,000.” Thus, the “stated” value of the stock and put option was between $700,000 and $900,000. The Stock Purchase Agreement valued the stock, providing that each share of Vista stock issued to Dr. Neumann “shall have a value equal to the closing sale price” of Vista’s common stock reported on NASDAQ’s Automatic Quotation System on the closing date of the transaction. Dr. Neu-mann testified that for income tax purposes, he reported a value of $450,000 for the stock.

The Stock Purchase Agreement provided for a legend concerning restrictions on the sale of the 100,000 shares to be placed on the stock certificate. The legend was placed on the stock certificate and stated in part that “[t]he shares represented by this certificate have not been registered under the Securities Act of 1933, as amended (the ‘Federal Act’), or the securities laws of any state or other jurisdiction, but have been acquired by the registered owner for purposes of investment....” The legend also stated in part that the shares could not be sold without being registered, unless an exemption was available under applicable securities laws.

The Put Option Agreement provided that Dr. Neumann could exercise the option to put the 100,000 shares to Vista at specified strike prices during either one of two specified exercise periods. During the first exercise period, which began on January 1, 1999 and ended on February 1, 1999, the strike price was $7.00 per share. During the second exercise period, which began on January 1, 2000 and ended on February 1, 2000, the strike price was $9.00 per share. The option was exercisable only if the average closing sale price for publicly traded shares of Vista’s common stock, as defined in the Put Option Agreement for periods specified ending on the day before each of the respective exercise periods, was less than the strike price for each such period. The option was not transferrable “except by the laws of descent and distribution” and could only be exercised with respect to the shares received by Dr. Neumann at the closing. The Put Option Agreement provided that it was governed by Georgia law and in particular stated in subparagraph 2(f) that “[Vista] shall have no obligation to make any payment under § 2(e) hereof if such payment would not be permitted under § 14-2-640 of the Georgia Business Corporation Code.”

Vista’s financial statements filed annually as part of Form 10-K with the U.S. Securities and Exchange Commission showed Dr. Neumann’s interest in the company as redeemable common stock, which the accountants inserted in the balance sheet above the equity section and below long-term debt. The accounting treatment has no legal implication other than it correctly reflected that Dr. Neu-mann held a contingent claim against Vista, in addition to the 100,000 shares of Vista stock.

The put arrangement enabled Vista to acquire Midwest Vision, Inc. without hav *617 ing to outlay additional cash in 1997. If its shares traded at prices higher than the strike prices during the two exercise periods, Vista would have avoided having to pay any additional cash to Dr. Neumann. Dr. Neumann testified that he viewed the option agreement as an undertaking by Vista to guarantee him the purchase price for his shares in Midwest. If he had been able to convert the shares to cash in January 2000, Dr. Neumann would have achieved what he contends was his initial goal: a cash sale price $900,000 higher than the value of the consideration other than the securities he had accepted for his stock in Midwest. He was free not to exercise the option, however. Indeed, when asked by the Court whether, if the share price had risen to $20 in January 2000, he would have been in fine shape, Dr. Neumann responded in the affirmative.

After the deal closed, Dr. Neumann was employed by Vista.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Paratransit Risk Retention Group Insurance Co. v. Kamins
160 P.3d 307 (Colorado Court of Appeals, 2007)
Deutsche Bank A.G. London Branch v. Worldcom, Inc.
357 B.R. 223 (S.D. New York, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
283 B.R. 613, 2002 Bankr. LEXIS 1066, 40 Bankr. Ct. Dec. (CRR) 57, 2002 WL 31174521, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vista-eyecare-inc-v-neumann-in-re-vista-eyecare-inc-ganb-2002.